AI Generated Content

This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.

Zydus Life’s US arm gets FDA nod for first-ever Menkes disease treatment

SUMMARY

AI Generated Content
  • USFDA OKs Sentynl's ZYCUBO®: First approved Menkes disease therapy.
  • ZYCUBO® shows 80% mortality risk reduction, survival increase in trials.
  • Zydus arm gains rare disease foothold with copper histidinate approval.
AD
Other Interesting Stories
AD